Investigador Doctor

Dra. Beatriz Salinas Rodríguez

Dra. Beatriz
Salinas Rodríguez


Beatriz Salinas Rodríguez received her MSc in Chemistry in 2009 from the Universidad de Salamanca, Spain, where she worked on the design of layered double hydroxide monohybrids for drug delivery. In 2009 she received a 4 years fellowship from the Spanish Government to start her PhD at the Universidad Complutense de Madrid (UCM) and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain. In 2013 she obtained her PhD degree on the synthesis and covalent functionalization of superparamagnetic nanoparticles for biomedical imaging. After that, she joined Memorial Sloan Kettering Cancer Center (New York, USA, 2013-2015) as a postdoctoral research fellow, where she focused her studies in the design of new PET and SPECT tracers for glioblastoma imaging.

In January 2016 she joined the Biomedical Imaging and Instrumentation Group at the Hospital Gregorio Marañon (Madrid, Spain), where she is working on the design and development of new tracers and molecular probes for nuclear and optical imaging.


Bachelor in Biomedical Engineering, Universidad Carlos III de Madrid:

- Introduction to Biomedical Engineering (2016, 2017)

- Biomedical applications of nanotechnology (2017)

Master en Terapias Avanzadas, Universidad Francisco Vitoria

- Casos prácticos: del laboratorio a la clínica (2017, 2018)

Master in laboratory animal science and welfare, Universidad Autonoma de Barcelona

- Imaging techniques; Positron Emission Tomography (2017)

Master Física Médica,  UNED

- Síntesis de radiofármacos (módulo de prácticas) 2018

Selected Publications

[1] S. Jannetti, G. Carlucci, B. Carney, S. Kossatz, L. Shenker, L. Carter, B. Salinas, C. Brand, A. Sadique, M. Gönen, V. Ponomarev, B. Zeglis, J. Lewis, W.A. Weber, J. Humm, T. Reiner., PARP1-Targeted Radiotherapy in mouse models of glioblastoma. Journal of Nuclear Medicine., 2018 in press 
[2] Carney B*, Carlucci G*, Salinas B, Di Gialleonardo V, Kossatz S, Vansteene A, Longo VA, Bolaender A, Chiosis G, Keshari KR, Weber WA, Reiner T. Non-invasive PET imaging of PARP1 expresion in glioblastoma models. Mol Imaging Biol. Vol 18(3), 2016 pp 386-392.
[3] Salinas B., Irwin CP., Kossatz S., Bolaender A., Chiosis G., Pillarsetty N., Weber WA., Reiner T. Radioiodinated PARP1 Tracers for Glioblastoma Imaging. European Journal of Nuclear Medicine and Molecular Imaging Research. Vol 5 (1) 2015, pp123
[4] Salinas B., Ruiz-Cabello J., Lechuga-Viesco A.V., Benito M, Herranz F. Surface-functionalized nanoparticles by olefin metathesis: A chemoselective approach for in vivo characterization of atherosclerosis plaque. Chemistry. Vol 21 (29), 2015, pp 10450-6.
[5] Irwin CP, Portorreal Y, Brand C, Zhang Y, Desai P, Salinas B, Weber W, Reiner T. PARPi-FL a fluorescent PARP1 inhibitor for glioblastoma imaging. Neoplasia. Vol 16 (5), 2014, pp 432-40.
[6] Herranz F., Salinas B., Groult H., Pellico J., Lechuga-Vieco A.V., Vabesh R., Ruiz-Cabello J. Superparamagnetic nanoparticles for atherosclerosis imaging. Nanomaterials 4(2), 2014, 408-438
[7] San Roman M.S., Holgado M. J., Salinas B., Rives V. Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites. Aplied Clay Science, Vol 71, 2013, pp 1-7
[8] Salinas B., Ruiz-Cabello J.,Morales M.P., Herranz F. Olefin metathesis for the functionalization of superparamagnetic nanoparticles. Bioinspire, Biomimetic and Nanobiomaterials, Vol.,1 (3), 2012, pp.166-172.
[9] San Roman M. S., Holgado M. J., Salinas B., Rives V. Characterization of Diclofenac, Ketoprofen or Chloranphenicol succinate encapsulated in layered double hydroxides with the hydrotalcite-type. Aplied Clay Science, Vol 55, 2012, pp. 158-163.
[10] Herranz F., Almarza E., Rodríguez I, Salinas B., Rosell Y. Desco M., Bulte J.W.M, Ruiz-Cabello J. Nanoparicles for gene therapy and magnetic resonance imaging. Microscopy Research and Technique Vol., 74, 2011, pp: 577-591

Instituto de Investigación Sanitaria Gregorio Marañón
C/ Ibiza 43. Anexo Psiquiatría 1ª planta
28009 Madrid
+34 91 426 5067 Ext 15